TMEM39B Inhibitors
Chemical inhibitors of TMEM39B disrupt its proper functioning through various mechanisms impacting cellular transport and protein processing. Brefeldin A directly targets vesicle trafficking between the Golgi apparatus and the endoplasmic reticulum by inhibiting ADP-ribosylation factor, a small GTPase essential for vesicle movement. This action hampers the transportation and correct localization of TMEM39B within the cell. Monensin, an ionophore, alters the Golgi function by changing its pH, which subsequently affects the localization and function of TMEM39B. Tunicamycin's role in inhibiting N-linked glycosylation affects the glycosylation process of TMEM39B, potentially leading to improper folding and functioning of the protein. Cyclosporin A, by inhibiting calcineurin, disrupts dephosphorylation processes that can have downstream effects on the trafficking and functionality of TMEM39B.
Dynasore, by inhibiting the GTPase dynamin, impedes the endocytosis process, which is crucial for the recycling and redistribution of TMEM39B to the appropriate cellular locales. Similarly, chlorpromazine disrupts clathrin-mediated endocytosis, a pathway that could be vital for the internalization and subsequent trafficking of TMEM39B. Nocodazole and colchicine both target the polymerization of microtubules, a key component in intracellular vesicle transport, potentially leading to the inhibition of TMEM39B movement within the cell. Swinholide A and cytochalasin D disrupt the actin cytoskeleton by severing actin filaments and inhibiting polymerization, respectively, which can affect the position and movement of organelles and vesicles, thus influencing TMEM39B distribution and function. Lastly, oligomycin compromises mitochondrial ATP synthase, which can result in decreased ATP levels within the cell; ATP is a molecule critical for many cellular processes, including those that govern vesicle trafficking and protein function, thereby affecting the activity of TMEM39B.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits ADP-ribosylation factor (ARF), a small GTPase involved in vesicle trafficking between the Golgi and the endoplasmic reticulum. By inhibiting ARF, Brefeldin A disrupts the trafficking and localization of TMEM39B, leading to its functional inhibition. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts intracellular ion gradients. It affects the Golgi function by altering its pH, which can subsequently inhibit the correct localization and function of TMEM39B within the Golgi apparatus. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation by blocking the first step in the synthesis of the lipid-linked oligosaccharide precursor. This can inhibit the glycosylation of TMEM39B, which is necessary for its proper folding and function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that inhibits calcineurin. Since calcineurin mediates dephosphorylation events that affect the trafficking and function of transmembrane proteins, its inhibition could disrupt the function of TMEM39B. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits dynamin, a GTPase required for vesicle scission during endocytosis. Inhibition of endocytosis could impair the recycling and distribution of TMEM39B to its appropriate cellular locations, thereby inhibiting its function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. If TMEM39B function depends on phosphorylation by a tyrosine kinase, genistein could inhibit its activity by preventing this phosphorylation. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is known to interfere with clathrin-mediated endocytosis. By disrupting this process, it could prevent the internalization and subsequent trafficking of TMEM39B, which is necessary for its proper cellular function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization. As microtubules are essential for vesicle transport within cells, their disruption can inhibit the intracellular trafficking of TMEM39B, which is necessary for its function. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin and inhibits microtubule polymerization. Similar to nocodazole, it can impede the trafficking of TMEM39B by disrupting the microtubule network and thus its function. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D inhibits actin polymerization. By disrupting the actin cytoskeleton, it can affect the positioning and movement of vesicles and organelles, potentially leading to the inhibition of TMEM39B trafficking and function. | ||||||